Search results for "Infectious"

showing 10 items of 2953 documents

Acquisition of Class C β-Lactamase PAC-1 by Sequence Type 644 Strains of Pseudomonas aeruginosa

2019

Four sequence type 664 (ST664) (serotype O:5) strains of Pseudomonas aeruginosa that were highly resistant to antibiotics, including ceftolozane-tazobactam and ceftazidime-avibactam, but were susceptible to colistin were found to harbor the gene encoding the rare class C β-lactamase PAC-1 on a chromosomally located Tn 1721 -like transposon. The bla PAC-1 gene was associated with the 16S rRNA methylase determinant rmtF2 , which confers pan-aminoglycoside resistance.

PharmacologyTransposable elementSerotype0303 health sciencesLineage (genetic)030306 microbiologymedicine.drug_classPseudomonas aeruginosaAntibioticseducationBiologymedicine.disease_cause16S ribosomal RNA3. Good healthMicrobiology03 medical and health sciencesInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyColistinmedicinePharmacology (medical)Gene030304 developmental biologymedicine.drug
researchProduct

Mathematical models for the management of helminth parasites: from biological processes to the evolution of anthelmintic resistance

2010

International audience; Helminth parasitic diseases are mainly controlled by anthelmintic treatments, but control schemes are now threatened by the large development of anthelmintic resistance. Integrated parasite management needs to be developed but processes underpinning parasite population dynamics and resistant gene evolution are still lacking. Here, we review the mathematical models that have been developed to understand the evolution of anthelmintic resistance in host-helminth parasite models (intestinal helminth parasites of herbivores and human soil-transmitted helminths). A first part is dedicated to generic models that allowed the understanding of processes underlying host-helmint…

Pharmacology[SDE] Environmental Sciences0303 health sciencesResistance (ecology)ANTHELMINTIC RESISTANCEHELMINTH[SDV]Life Sciences [q-bio]030231 tropical medicineZoologyBiology030308 mycology & parasitology[SDV] Life Sciences [q-bio]03 medical and health sciencesPOPULATION DYNAMICS0302 clinical medicineInfectious DiseasesINTEGRATED PARASITE MANAGEMENTparasitic diseases[SDE]Environmental SciencesmedicineHelminthsAnthelminticMATHEMATICAL MODELSmedicine.drug
researchProduct

Conjugated vaccines: A new strategy for prevention and protection against pediatric infectious diseases

2002

Pharmacologybusiness.industryPediatric Infectious DiseaseConjugated vaccinesbook.journalMedicinePharmacology (medical)businessbookVirologyCurrent Therapeutic Research
researchProduct

Factors Associated with Anti-SARS-CoV-2 Vaccine Acceptance among Pregnant Women: Data from Outpatient Women Experiencing High-Risk Pregnancy

2023

Pregnant women are at higher risk of severe Coronavirus disease 2019 (COVID-19) complications than non-pregnant women. The initial exclusion of pregnant women from anti-SARS-CoV-2 vaccines clinical trials has caused a lack of conclusive data about safety and efficacy for this vulnerable population. This cross-sectional study aims to define the factors related to vaccination adherence in a sample of women experiencing high-risk pregnancies. The recruited women completed a questionnaire based on the Health Belief Model. Data were analyzed to evaluate the associations between socio-demographic variables and vaccination acceptance through descriptive, univariate and multivariate logistic analys…

PharmacologycommunicationImmunologyvaccine acceptanceInfectious Diseaseseducational levelDrug Discoverygynecologistanti-SARS-CoV-2 vaccinationbarriervaccine hesitancyPharmacology (medical)high-risk pregnant womenCOVIDHealth Belief ModelCOVID Health Belief Model anti-SARS-CoV-2 vaccination barrier communication educational level gynecologist high-risk pregnant women vaccine acceptance vaccine hesitancy
researchProduct

Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo’s Province, Italy: From Influenza t…

2022

In Italy, following the start of the SARS-CoV-2 vaccination campaign, community pharmacies (CPs) were recruited on a voluntary basis in order to administer COVID-19 vaccines as part of their activities. The aim of the present study was to investigate the knowledge, attitudes, and practices regarding SARS-CoV-2 infection prevention, and vaccine acceptance/hesitancy towards COVID-19 and influenza vaccinations among the community pharmacists operating in the Palermo Province. A cross-sectional study was conducted, with two different questionnaires administered before and after the conduction of the vaccination campaign against SARS-CoV-2 at the COVID-19 vaccination center of the Palermo Univer…

Pharmacologycommunity pharmacistInfectious DiseasesCOVID-19 vaccinationSARS-CoV-2 infectionhealthcare professionalDrug DiscoveryImmunologyPharmacology (medical)influenza vaccinationvaccine hesitancy.influenza vaccination; COVID-19 vaccination; community pharmacists; KAPs; vaccine hesitancy; healthcare professionals; SARS-CoV-2 infectionVaccines
researchProduct

COVID-19 Vaccination in Migrants and Refugees: Lessons Learnt and Good Practices.

2022

The COVID-19 pandemic has exacerbated inequalities between low- and high-income countries. Within the latter, a greater impact is seen in the poorest and most vulnerable people, including refugees, asylum seekers, and migrants. They all may experience poor access to quality healthcare or have suboptimal health-seeking behavior, distrust of governments, or fear of detention and deportation if seeking healthcare. Some refugees and migrants may face multiple barriers to vaccination and access to health systems that are relevant to the administration of COVID-19 vaccines, despite the growing inclusion of these populations in public health policies. Several good practices have emerged to ensure …

Pharmacologyhealth policieImmunologyCOVID-19global healthimmunizationSettore MED/42 - Igiene Generale E ApplicatamigrantInfectious Diseasesvulnerable groupsvaccineDrug DiscoveryPharmacology (medical)refugeeVaccines
researchProduct

Influenza and Other Prophylactic Vaccination Coverage in Polish Adult Patients Undergoing Allergen Immunotherapy-A Survey Study among Patients and Ph…

2022

Vaccines against infectious diseases may raise safety concerns in patients undergoing allergen immunotherapy (AIT). The objective of our study was to investigate influenza vaccine and other selected prophylactic vaccines coverage in patients treated with AIT and the attitude of physicians towards vaccinations in this group of patients. We conducted a questionnaire-based study among patients undergoing AIT and physicians. The patients’ survey evaluated influenza and other prophylactic vaccines coverage. The physicians’ survey assessed their experience and opinions on prophylactic vaccinations during AIT. In total, 176 patients (aged 18–79 years) and 120 doctors filled the q…

Pharmacologyinfluenza vaccine; allergen immunotherapy; prophylactic vaccines; vaccine coverageInfectious DiseasesDrug DiscoveryImmunologyPharmacology (medical)Vaccines
researchProduct

A Knowledge, Attitude, and Perception Study on Flu and COVID-19 Vaccination during the COVID-19 Pandemic: Multicentric Italian Survey Insights

2022

In January 2020, Chinese health authorities identified a novel coronavirus strain never before isolated in humans. It quickly spread across the world, and was eventually declared a pandemic, leading to about 310 million confirmed cases and to 5,497,113 deaths (data as of 11 January 2022). Influenza viruses affect millions of people during cold seasons, with high impacts, in terms of mortality and morbidity. Patients with comorbidities are at a higher risk of acquiring severe problems due to COVID-19 and the flu—infections that could impact their underlying clinical conditions. In the present study, knowledge, attitudes, and opinions of the general population regarding COVID-19 and influenza…

PharmacologyknowledgeattitudesCOVID-19 vaccinationVaccinationImmunologyCOVID-19COVID-19; COVID-19 vaccination; attitudes; flu vaccination; knowledge; perception; vaccinationperceptionvaccinationCOVID-19; knowledge; attitudes; perception; vaccination; flu vaccination; COVID-19 vaccinationKnowledgeInfectious DiseasesAttitudeAttitudesflu vaccinationDrug DiscoveryPerceptionPharmacology (medical)Flu vaccination
researchProduct

The impact of mandatory vaccination law in Italy on mmr coverage rates in two of the largest italian regions (Emilia-romagna and sicily): An effectiv…

2020

Background: Vaccine hesitancy has increased worldwide, leading to reduction in vaccination coverage rates. In particular, reduction in the coverage for the trivalent Measles-Mumps-Rubella vaccine has led to an increase of measles cases. The aim of this study is to analyze the coverage rates for the MMR vaccine in the Emilia-Romagna Region (RER) and Sicily Region (SR) between 2009 and 2018, and to correlate any significant change to index events which could have modified the trend of vaccination rates. Methods: Official aggregate data on vaccination coverage at 24 months provided by the RER and the SR were analyzed through trend analysis and related to important index events. Results: The tw…

Pharmacologylcsh:RImmunologycoverage rateslcsh:MedicineMMR vaccinemedicine.diseaseMandatory vaccinationMeaslesArticleVaccinationMandatory vaccinationTrend analysisInfectious DiseasesGeographyVaccination coverageDrug DiscoverymedicinePharmacology (medical)Aggregate datamandatory vaccinationsCoverage rateVaccine hesitancyDemography
researchProduct

Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy

2022

Evidence on the human papillomavirus (HPV) vaccine shows that it is effective in reducing the burden of HPV-related diseases. For more than 15 years the HPV vaccine has been offered free of charge in Italy to girls from the age of 12. Over time, the free offer of the HPV vaccine has also been extended to boys and to young adults at risk of developing HPV lesions. Despite the HPV vaccine’s effectiveness and availability, vaccination coverage is low in Italy, with a reported value of 46.5% in 2020. Furthermore, in the southern administrative regions, vaccination coverage is even lower than national values, with 25.9% coverage in Sicily. A cross-sectional study was conducted among university a…

Pharmacologylow vaccination coverageInfectious Diseasesvaccine sources of information.Drug DiscoveryImmunologyPharmacology (medical)Settore MED/42 - Igiene Generale E ApplicataHPV vaccine; behavioral model; Health Belief Model; health literacy; vaccine sources of information; low vaccination coveragehealth literacyHPV vaccineHealth Belief Modelbehavioral modelVaccines; Volume 10; Issue 7; Pages: 998
researchProduct